Veradigm (NASDAQ:MDRX) Stock Price Up 10.9% – What’s Next?

Veradigm Inc. (NASDAQ:MDRX) shares shot up 10.9% during mid-day trading on Monday . The company traded as high as $10.65 and last traded at $10.65. 11,507 shares changed hands during trading, a decline of 99% from the average session volume of 1,610,281 shares. The stock had previously closed at $9.60.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on shares of Veradigm in a research note on Saturday. They issued a “hold” rating for the company. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $12.00.

Veradigm Price Performance

The stock has a 50-day moving average price of $9.54 and a two-hundred day moving average price of $9.29.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Veradigm stock. Tyro Capital Management LLC bought a new position in Veradigm Inc. (NASDAQ:MDRX) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,176,015 shares of the software maker’s stock, valued at approximately $9,055,000. Veradigm comprises 5.2% of Tyro Capital Management LLC’s holdings, making the stock its 10th biggest holding. Tyro Capital Management LLC owned approximately 1.08% of Veradigm as of its most recent SEC filing.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.